The Complement System in Inflammatory Bowel Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2014-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MIB.0000000000000056PMID 24831561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in IBD genetics

  2014cited by this paper
• Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

  2014influential reference
• The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapy.

  2014influential reference
• Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial

  2014cited by this paper
• Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.

  2014cited by this paper
• Humoral Pattern Recognition and the Complement System

  2013cited by this paper
• New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties.

  2013cited by this paper
• Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement

  2013cited by this paper
• The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL‐4 and IL‐10

  2013influential reference
• C5L2: a controversial receptor of complement anaphylatoxin, C5a

  2013influential reference
• Letter to Editor

  2013cited by this paper
• Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.

  2013influential reference
• Ficolins in complement activation.

  2013cited by this paper
• Complement Factor B Is the Downstream Effector of TLRs and Plays an Important Role in a Mouse Model of Severe Sepsis

  2013cited by this paper
• A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)

  2013cited by this paper
• The role of complement in CD4⁺ T cell homeostasis and effector functions.

  2013cited by this paper
• Complement in Immune and Inflammatory Disorders: Therapeutic Interventions

  2013cited by this paper
• Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.

  2013influential reference
• Complement-Dependent Injury and Protection in a Murine Model of Acute Dextran Sulfate Sodium-Induced Colitis

  2012cited by this paper
• Novel roles of complement in T effector cell regulation.

  2012cited by this paper
• Regulation of humoral immunity by complement.

  2012cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• Mannan-binding lectin deficiency - Good news, bad news, doesn't matter?

  2012cited by this paper
• Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice

  2012cited by this paper
• Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway.

  2012cited by this paper
• Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

  2012cited by this paper
• Intravenous immunoglobulin for the treatment of Crohn's disease.

  2012cited by this paper
• Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

  2011influential reference
• Association of genetic variants of mannan-binding (MBL) lectin-2 gene, MBL levels and function in ulcerative colitis and Crohn’s disease

  2011influential reference
• Eculizumab

  2011cited by this paper
• C4b-Binding Protein: A Forgotten Factor in Thrombosis and Hemostasis

  2011cited by this paper
• Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease

  2011influential reference
• Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis

  2011influential reference
• A Novel Role for CD46 in Wound Repair

  2011cited by this paper
• Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.

  2011cited by this paper
• Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

  2010cited by this paper
• Crosstalk pathways between Toll-like receptors and the complement system.

  2010cited by this paper
• The increased mucosal mRNA expressions of complement C3 and interleukin‐17 in inflammatory bowel disease

  2010cited by this paper
• Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.

  2010cited by this paper
• New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System

  2010cited by this paper
• Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens

  2010cited by this paper
• Molecular mechanisms of late apoptotic/necrotic cell clearance

  2010cited by this paper
• Inflammatory bowel diseases in patients with adaptive and complement immunodeficiency disorders.

  2010cited by this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental Colitis

  2010cited by this paper
• Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.

  2009influential reference
• Pentraxins: Multifunctional proteins at the interface of innate immunity and inflammation

  2009cited by this paper
• Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate‐induced models of inflammatory bowel disease

  2009cited by this paper
• Anti-inflammatory actions of intravenous immunoglobulin.

  2008cited by this paper
• Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.

  2008cited by this paper
• Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.

  2008influential reference
• The Role of Dendritic Cells in the Development of Acute Dextran Sulfate Sodium Colitis

  2007cited by this paper
• Letter to the editor

  2007cited by this paper
• The Role of Mannan-Binding Lectin (MBL) Gene Polymorphism in Ulcerative Colitis

  2007cited by this paper
• The Role of Dendritic Cells in the Development of Acute Dextran Sulfate Sodium Colitis1

  2007cited by this paper
• Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association

  2007cited by this paper
• Mannose-binding lectin and maladies of the bowel and liver.

  2006cited by this paper
• Suppression of experimental colitis by intestinal mononuclear phagocytes

  2006cited by this paper
• Generation of C5a in the absence of C3: a new complement activation pathway

  2006cited by this paper
• Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.

  2005cited by this paper
• Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis

  2005cited by this paper
• Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation

  2005cited by this paper
• Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease1

  2004cited by this paper
• A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease 1

  2003cited by this paper
• Complement activation in plasma before and after Infliximab treatment in Crohn disease

  2003cited by this paper
• High Normal Serum Levels of C3 and C1 Inhibitor, Two Acute-Phase Proteins Belonging to the Complement System, Occur More Frequently in Patients with Crohn's Disease Than Ulcerative Colitis

  2003influential reference
• Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

  2003cited by this paper
• Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor‐alpha deficient mice

  2003cited by this paper
• Colitis associated with deficiency of the sixth component of complement and congenital chronic neutropenia

  2001cited by this paper
• Intestinal Trefoil Factor Induces Decay-Accelerating Factor Expression and Enhances the Protective Activities Against Complement Activation in Intestinal Epithelial Cells1

  2001cited by this paper
• Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn’s disease

  2001influential reference
• C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells

  2001cited by this paper
• Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.

  2000cited by this paper
• Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn’s disease

  2000cited by this paper
• Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract

  1998influential reference
• Local and Systemic Complement Activity in Small Intestinal Bacterial Overgrowth

  1997cited by this paper
• Complement activation of electrogenic ion transport in isolated rat colon.

  1997cited by this paper
• Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils.

  1997cited by this paper
• The C5a chemoattractant receptor mediates mucosal defence to infection

  1996cited by this paper
• Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.

  1996cited by this paper
• Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines.

  1996cited by this paper
• Local secretion of complement C3 in the exocrine pancreas: ductal epithelial cells as a possible biosynthetic site.

  1996cited by this paper
• Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)

  1996cited by this paper
• The expression of complement protein 4 and IgG3 in luminal secretions.

  1996cited by this paper
• Multifunctional effects of anticomplementary agent K‐76 on carrageenan‐induced colitis in the rabbit

  1993cited by this paper
• Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.

  1993cited by this paper
• New treatment of ulcerative colitis with K-76

  1992influential reference
• Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

  1992cited by this paper
• Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.

  1990cited by this paper
• Enhanced local production of complement components in the small intestines of patients with Crohn's disease.

  1990cited by this paper
• Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

  1987influential reference
• Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.

  1985influential reference
• Defective release of C5a related chemo-attractant activity from complement in Crohn's disease.

  1983cited by this paper
• Circulating immune complexes in Crohn's disease

  1982cited by this paper
• Complement alterations in inflammatory bowel disease.

  1979cited by this paper
• The humoral immune system in inflammatory bowel disease

  1978cited by this paper
• C3 metabolism in ulcerative colitis and Crohn's disease.

  1977cited by this paper
• Humoral immune system in inflammatory bowel disease: I. Complement levels.

  1977cited by this paper
• The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.

  1976cited by this paper
• Humoral immune system activity in inflammatory bowel disease.

  1975cited by this paper
• Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.

  1975cited by this paper

• Divergent roles for complement components C3 and C4 in controlling Klebsiella pneumoniae gut colonization and systemic dissemination

  2026cites this paper
• Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement

  2025cites this paper
• Divergent roles for complement components C3 and C4 in controlling Klebsiella pneumoniae gut colonization and systemic dissemination

  2025cites this paper
• Colon‐targeted complement C5a1 receptor inhibition using pH‐sensitive nanoparticles ameliorates experimental colitis

  2025cites this paper
• Proteomic Profile of Human Colon Organoids: Effects of a multi-mineral intervention alone and in the presence of pro-Inflammatory and anti-inflammatory treatments

  2025cites this paper
• C5a peptidase (ScpA) activity towards human type II and type III interferons.

  2024cites this paper
• Transcriptomic Module Discovery of Diarrhea-Predominant Irritable Bowel Syndrome: A Causal Network Inference Approach

  2024cites this paper
• Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization

  2024cites this paper
• Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms

  2024influential citation
• Serum proteome profiles in cats with chronic enteropathies

  2023cites this paper
• The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.

  2023cites this paper
• Can eculizumab be an option in traditional treatment-resistant ulcerative colitis?

  2023cites this paper
• The correlates of neonatal complement component 3 and 4 protein concentrations with a focus on psychiatric and autoimmune disorders

  2023cites this paper
• Activation of the complement system by nanoparticles and strategies for complement inhibition.

  2023cites this paper
• Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases

  2023cites this paper
• Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn's Disease

  2022cites this paper
• A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins

  2022cites this paper
• Retinal drusen counts are increased in inflammatory bowel disease, and with longer disease duration, more complications and associated IgA glomerulonephritis

  2022cites this paper
• Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an in vitro interstitial cystitis/bladder pain syndrome model

  2022cites this paper
• Dietary mannan oligosaccharides strengthens intestinal immune barrier function via multipath cooperation during Aeromonas Hydrophila infection in grass carp (Ctenopharyngodon Idella)

  2022cites this paper
• Evaluating the clinical application of the immune cells’ ratios and inflammatory markers in the diagnosis of inflammatory bowel disease

  2022cites this paper
• Systematic Characterization of the Disruption of Intestine during Liver Tumor Progression in the xmrk Oncogene Transgenic Zebrafish Model

  2022cites this paper
• Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of <italic toggle='yes'>Vibrio cholerae</italic> O-Specific Polysaccharide-Specific Monoclonal Antibodies

  2021cites this paper
• Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine

  2021cites this paper
• Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis

  2021cites this paper
• Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies

  2021cites this paper
• Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis

  2020cites this paper
• Complement system network in cell physiology and in human diseases

  2020cites this paper
• The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment

  2020cites this paper
• Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells

  2020cites this paper
• Multi-omics in IBD biomarker discovery: the missing links

  2019cites this paper
• Expression of Antisense Long Noncoding RNAs as Potential Regulators in Rainbow Trout with Different Tolerance to Plant-Based Diets

  2019cites this paper
• Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer

  2019cites this paper
• Challenge to the Intestinal Mucosa During Sepsis

  2019cites this paper
• Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

  2019cites this paper
• Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies.

  2019cites this paper
• The Complexity of Renal Involvment in IBD-C3 Glomerulopathy in Ulcerative Colitis.

  2018cites this paper
• The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.

  2018cites this paper
• Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort

  2018cites this paper
• Immunomodulatory Functions of the Gastrointestinal Tract

  2018cites this paper
• Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria.

  2018cites this paper
• Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms

  2018cites this paper
• The anaphylatoxin C3a primes model colonic epithelial cells for expression of inflammatory mediators through G&agr;i

  2018cites this paper
• Glycans as critical regulators of gut immunity in homeostasis and disease.

  2018cites this paper
• THE ERA OF PLANT BASED MEDICINE- AN OVERVIEW

  2017cites this paper
• Effectiveness of C5a aptamers in a TNBS-induced colitis mouse model.

  2017cites this paper
• Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?

  2017cites this paper
• Immune-mediated processes in neurodegeneration: where do we stand?

  2016cites this paper
• Complement component 6 deficiency increases susceptibility to dextran sulfate sodium-induced murine colitis.

  2016cites this paper
• Properdin Provides Protection from Citrobacter rodentium–Induced Intestinal Inflammation in a C5a/IL-6–Dependent Manner

  2015cites this paper
• Nutrigenomic profiling of transcriptional processes affected in liver and distal intestine in response to a soybean meal-induced nutritional stress in Atlantic salmon (Salmo salar).

  2015cites this paper
• Properdin Regulation of Complement Activation Affects Colitis in Interleukin 10 Gene–Deficient Mice

  2015cites this paper
• EXPLORING THE POSSIBLE ROLE OF C3aR LIGATION ON INTESTINAL EPITHELIAL CELLS

  2014cites this paper